Latest News
Outcome Disparities in Pediatric Sepsis By Ethnicity, Insurance Status
Janssen Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization
Untreated Obstructive Sleep Apnea Linked to More Influenza Hospitalizations
AAP Releases 2021 Child and Adolescent Immunization Schedule
Serum Cytokine Concentrations Early in COVID-19 Infection as Biomarker of Disease Severity
Individuals With Highest HIV Infection Rates Insured by Medicaid Less Likely to Persist With HIV Pre-Exposure Prophylaxis
Mucocutaneous Symptoms of Multisystem Inflammatory Syndrome in Pediatric Patients
Predictors of Immigrants’ Depression and Anxiety During COVID-19 Pandemic
Skin Infections in Early Childhood Linked to Pediatric Psoriasis
People Living With HIV May Have Worse COVID-19 Outcomes
Updates to the 2021 Adult Immunization Schedule
Protection From HIV With Pre-Exposure Prophylaxis May be Accurately Assessed in Urine Samples
Pfizer-BioNTech COVID-19 Vaccine: New Storage Conditions Approved; Booster Dose Study Initiated
Latest Features & Opinion
COVID-19 Vaccine Efficacy After First Dose: Pfizer, Moderna, AstraZeneca
New data about Pfizer COVID-19 efficacy after the first dose suggests high efficacy, raising questions about potential alternative dosing schedules.
Oxford-AstraZeneca COVID-19 Vaccine: New Study Results, Variant Coverage Update, Where Do We Stand?
The Oxford-AstraZeneca COVID-19 vaccine, ChAdOx1, released 4 studies to analyze its efficacy in the prevention of mild, moderate, and severe COVID-19 infection; new studies also address rising concerns in the vaccine’s ability to protect against variants B.1.1.7 and B.1.351.
But Is it Fair? Bioethics, COVID-19 Vaccine Distribution, and Advocacy
We speak with Mildred Solomon, EdD, President of the Hastings Center and Professor of Global Health and Social Medicine at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, about the COVID-19 pandemic, health equity, and vaccine distribution.
COVID-19 Variants: Pfizer, Moderna Updates, and IDSA Media Briefing
Moderna and Pfizer provide updates on mRNA vaccines against variant B.1.1.7; Infectious Diseases Society of America holds media briefing on COVID-19 variants.
-
Loading...
-
Loading...
